In vitro antibacterial activities of two novel oral antibiotics, tebipenem and cefditoren, and other

来源 :第二届京港感染医师论坛 | 被引量 : 0次 | 上传用户:cxx163252
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background: Haemophilus influenzae, Streptococcus pneumoniae, and Streptococcus pyogenes are the most common causative bacterial pathogens of Community-acquired respiratory tract infections (CARTI), and an increase in their resistance to orally administered β-lactam agents has emerged as a global problem.Tebipenem and cefditoren are two novel oral antibiotics which exhibit a wide range of antibacterial activity.This study is to determine the in vitro activities of the two novel oral antibiotics and other comparators against CARTI-associated bacterial pathogens.Methods: A total of 275 isolates of S.pneumoniae, H.influenzae and S.pyogenes were isolated from 10 hospitals in six cities of China.The minimum inhibitory concentrations (MICs) of 16 antimicrobial agents were determined by using broth microdilution method.The H.influenzae isolates were examined for the production of β-1actamase using nitrocefin disks.
其他文献
目的 隐球菌脑膜炎是导致艾滋病患者死亡的一种严重机会性感染,虽然经过有效地抗隐球菌治疗,很多患者仍遗留持续高颅压。持续的颅内压升高是导致艾滋病合并隐球菌脑膜炎预后不佳的独立预测因素,会增加患者的死亡率。考虑到患者的免疫水平及合并感染等危险性,在该类患者中应用脑室腹腔引流降低颅内压受到限制。因此在艾滋病合并隐球菌脑膜炎患者中应用脑室腹腔引流有效降低颅内压的安全性及长期的有效性需要进一步进行验证。方法
Background: Avibactam is a member of a class of inhibitors called diazabicyclooctanes (DBOs) that does not contain a β-lactam core but maintains the capacity to covalently acylate its β-lactamase targ
Background Influenza virus is a global health concern due to its unpredictable pandemic potential.We previously found that severe influenza A(H1N1)pdm09 virus infection in humans was marked with a str
会议
女性患者,67岁,因双膝间断疼痛、活动受限9年,加重4个月.于201 1年4月25日收住我院骨关节科.入院1年前右膝关节游离体,于外院行关节镜关节腔清理,游离体取出术,术后疼痛减轻.2011年1月疼痛加剧,行走困难.患者患有2型糖尿病5年余,口服拜糖平治疗,血糖控制尚可.患高血压2 0年,口服拜新同治疗,血压130/70mmHg,血压可控.入院检查:右膝轻度肿胀,皮温不高,双侧髌骨研磨试验(Pat
会议
Background: Coagulation abnormalities may be a major impact on the outcome of sepsis patients.The aim of our study was to investigate if there were relations between miR-122 and coagulation disorder d
背景 近年来由于抗生素的广泛应用,细菌所产生的耐药性也逐年增强.细菌的耐药性具有地域特点,不同地区,甚至不同医院的细菌耐药性亦有所不同,故及时了解本地区和本医院的耐药状况,对指导临床合理应用抗菌素具有重要意义.本研究就我院2010年细菌的耐药性情况进行分析,了解我院临床分离菌株对常用抗菌素的耐药情况.方法 采用纸片扩散Kirby-Bauer法,对我院2010年分离的1 465株临床分离菌株作药物敏
会议
目的 探讨混合型肺曲霉病的临床特点,提高对该病的诊治水平.方法 肺曲霉病主要包括侵袭型(IPA)、过敏型(ABPA)、腐生型(曲菌球)3种类型.如果不同类型的肺曲霉病共存于一个患者身上,我们将其定义为混合型肺曲霉病(mixed types of pulmonary aspergillosis,MTPA).本研究回顾性分析2010年至2012年北京大学第一医院收治的3例MTPA的临床特点.
会议
Background: Campylobacter jejuni infection, traditionally a paediatric illness, is now seen more frequently in adolescents and adults in northern China.Published surveillance reports on C.jejuni infec
Purpose: We present a case study regarding a patient with recurrent keratoconjunctivitis that presented as an initial manifestation of common variable immune deficiency (CVID).Methods: We describe a c
会议
目的 对本院环境中鲍曼不动杆菌所致医院感染的危险因素进行分析,评估风险,提出防范措施。方法 收集我院因多重耐药鲍曼不动杆菌引起感染病例的病原菌,采集相应环境物表标本20份,分离鉴定其中的鲍曼不动杆菌,分析这些病原体所引起的感染患者的临床特点及临床分离菌和环境分离菌的耐药性差异。结果 3株多重耐药鲍曼不动杆菌来自临床病例,20份环境物表样品中分离出1株鲍曼不动杆菌。经鉴定4株鲍曼均为多重耐药菌,药敏